# Evidence Confirm Productionization RR-09 Runtime Re-evidence Controller Judgment

Verdict token:

`ACCEPT_RR_09_RUNTIME_REEVIDENCE_RESIDUALS_STILL_OPEN_NOT_READY`

## Scope

Gate: `RR-09 B1 Runtime Re-evidence / R1-R4 Live/PDF Re-evidence Controller Judgment`.

Reviewed artifacts:

- R1-R4 evidence: `docs/reviews/evidence-confirm-productionization-rr-09-a3-live-pdf-reevidence-20260624.md`
- B1 product evidence: `docs/reviews/evidence-confirm-productionization-rr-09-b1-runtime-product-cli-reevidence-20260624.md`

User authorization covered:

- `授权 RR-09 R1-R4 live/PDF re-evidence after A3 no-live fixes`
- `授权 RR-09 B1 runtime product CLI re-evidence for 017641 / 2024`

## Judgment

Accept both evidence artifacts as valid runtime evidence, but do not close RR-09 and do not claim release/readiness.

R1-R4 result:

- EID `single_source_only` provenance remained admitted for all four samples.
- Fallback remained disabled and unused.
- A3 closed the previous R3 `bond_risk_group_anchor_projection_gap`.
- Strict deterministic V2 still fails for all R1-R4 samples.
- R1/R2/R4 remain dominated by `coarse_reference_insufficient`.
- R3 now has no bond-risk group projection gap, but has `missing_section=3` in reference materialization and still fails value-match on coarse references.

B1 result:

- Product CLI exit code was `2`.
- `quality_gate_status=block`.
- stdout was empty, so report body remained suppressed.
- Evidence Confirm safe summary was preserved on stderr under the quality-gate block.
- `manager_strategy_text` still has P0/blocking FQ2/FQ3/FQ2F issues for `017641 / 2024`.
- Product Evidence Confirm status remains `fail` under `warn` policy.

## Accepted Facts

| Fact | Accepted status |
|---|---|
| R1-R4 source/PDF provenance after A3 | accepted; EID single-source, no fallback |
| A3 bond-risk group anchor projection for R3 | accepted as closed for current evidence |
| R1-R4 strict V2 runtime pass | rejected; still fail |
| R3 reference materialization clean pass | rejected; `missing_section=3` remains |
| B1 product quality-gate residual closure | rejected; `manager_strategy_text` still blocks |
| Branch F blocked-path EC safe summary propagation | accepted for `017641 / 2024` |
| Report body suppression under quality-gate block | accepted for `017641 / 2024` |
| Release/readiness | not accepted |

## Residual Routing

| Residual | Destination |
|---|---|
| R1/R2/R4 `coarse_reference_insufficient` | `RR-09 A4 R1-R4 Row-material Precision Residual Planning Gate` |
| R3 `coarse_reference_insufficient` plus `missing_section=3` | `RR-09 A4 R3 Missing-section / Row-material Precision Residual Planning Gate` |
| B1 `manager_strategy_text` P0 block for `017641 / 2024` | `RR-09 B1 Runtime Manager-strategy QDII Residual Planning Gate` |
| ECQ1 warning on product CLI | carried to RR-09 residual planning |
| Checklist Evidence Confirm support | deferred to separate checklist gate |
| Report-body Evidence Confirm rendering | deferred to separate report-body gate |
| Provider-backed semantic production default | deferred to separate provider/default gate |
| Tag/release/readiness | blocked until separate release-boundary authorization and accepted readiness evidence |

## Next Entry Point

`RR-09 A4 / B1 Runtime Residual Planning Gate`

The next plan must decide whether to:

- implement row/material precision fixes for R1-R4;
- diagnose R3 `missing_section=3`;
- implement or route additional QDII `manager_strategy_text` source-truth/extractor/anchor work for `017641 / 2024`;
- or explicitly classify a residual as accepted release-scope behavior with owner and risk statement.

No live/PDF/provider/LLM/product CLI/checklist/report-body/tag/release/readiness action is authorized by this judgment.

Release/readiness remains `NOT_READY`.

Completion token:

`ACCEPT_RR_09_RUNTIME_REEVIDENCE_RESIDUALS_STILL_OPEN_NOT_READY`
